Cardiovascular magnetic resonance and positron emission tomography provide essential non-invasive diagnostic, tissue characterization, and prognostic information for managing inflammatory cardiomyopathies.
This ESCR consensus document provides practical recommendations for using CMR and PET to non-invasively diagnose, risk-stratify, and follow up patients with acute myocarditis and chronic inflammatory cardiomyopathies.
Advanced cardiac imaging techniques such as cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) are widely used in clinical practice in patients with acute myocarditis and chronic inflammatory cardiomyopathies (I-CMP). We aimed to provide a review article with practical recommendations from the European Society of Cardiovascular Radiology (ESCR), in order to guide physicians in the use and interpretation of CMR and PET in clinical practice both for acute myocarditis and follow-up in chronic forms of I-CMP.
Caobelli et al. (Fri,) conducted a review in Acute myocarditis and chronic inflammatory cardiomyopathy. Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) was evaluated. Cardiovascular magnetic resonance and positron emission tomography provide essential non-invasive diagnostic, tissue characterization, and prognostic information for managing inflammatory cardiomyopathies.